IPO9

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, IPO9 mutation is significantly associated with the RNA expression of many other genes, with 2,935 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible IPO9-associated genes across cancer lineages are NUP43, ZWINT, and PIMREG. Each is linked with IPO9 in more than 3 cancer types. Because this analysis shows association rather than direction, both IPO9-to-partner and partner-to-IPO9 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (IPO9→partner) and Y-score (partner→IPO9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECNUP43 →+0.377+1.709<.001<.00134
UCECZWINT →+0.550+1.818.001.00334
UCECPIMREG →+0.562+1.709.003<.00134
COADCDCA8 →+0.613+3.210<.001.00934
UCECCENPO →+0.399+2.010.002.00534
UCECCCNA2 →+0.686+1.917<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest of 2,935 associations by consensus.

Exploration